Timing: A critical determinant of the functional consequences of neonatal 6-OHDA lesions

Neurotoxicology and Teratology

Volumn 21, Issue 2, 1999, Pages 129-140

  Neal Beliveau, Bethany S ^a   Joyce, Jeffrey N ^b  

^a INDIANA UNIVERSITY   (United States)

^b SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

6 Hydroxydopamine (6 OHDA); Development; Dopamine receptors; Functional plasticity; Neonatal DA lesions

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 ALLYL 2,3,4,5 TETRAHYDRO 1 PHENYL 1H 3 BENZAZEPINE 7,8 DIOL; APOMORPHINE; CARBIDOPA; DOPAMINE 1 RECEPTOR; DOPAMINE TRANSPORTER; LEVODOPA; MAZINDOL; NEUROTOXIN; OXIDOPAMINE; QUINPIROLE; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN INJURY; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DYSKINESIA; FEMALE; GROOMING; LOCOMOTION; MALE; NERVE CELL PLASTICITY; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; REARING; RECEPTOR SENSITIVITY; SUBCUTANEOUS DRUG ADMINISTRATION;

AGING; ANIMALS; ANIMALS, NEWBORN; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; CARRIER PROTEINS; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GROOMING; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; OXIDOPAMINE; PREGNANCY; PSYCHOMOTOR PERFORMANCE; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SYMPATHOLYTICS; TIME FACTORS;

EID: 0033056994     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0892-0362(98)00044-0     Document Type: Article

References (46)

1. 2 receptor mediation in rats depleted of dopamine as neonates. Dev. Psychobiol. 25:1992;475-495.
2. Braun A.R., Chase T.N. Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors. Eur. J. Pharmacol. 131:1986;301-306.
3. Breese G.R., Baumeister A.A., McCown T.J., Emerick S.G., Frye G.D., Crotty K., Mueller R.A. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists. Relevance to neurological symptoms in clinical syndromes with reduced brain dopamine J. Pharmacol. Exp. Ther. 231:1984;343-354.
4. 1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 235:1985;287-295.
5. Breese G.R., Criswell H.E., Johnson K.B., O'Callaghan J.P., Duncan G.E., Jensen K.F., Simson P.E., Mueller R.A. Neonatal destruction of dopaminergic neurons. Neurotoxicology. 15:1994;149-160.
6. 1 dopamine receptors in neonatally-lesioned rats J. Pharmacol. Exp. Ther. 234:1985;447-455.
7. 2 receptors in rats depleted of dopamine as neonates. Psychopharmacology (Berlin). 122:1995;85-94.
8. Bruno J.P., Jackson D., Zigmond M.J., Stricker E.M. Effect of dopamine-depleting brain lesions in rat pups. Role of striatal serotonergic neurons in behavior Behav. Neurosci. 99:1987;806-811.
9. Bruno J.P., Stricker E.M., Zigmond M.J. Rats given dopamine-depleting brain lesions as neonates are subsensitive to dopaminergic antagonists as adults. Behav. Neurosci. 99:1985;771-775.
10. 2-like receptors is unnecessary for stimulated motor behavior in rats depleted of dopamine during development. Behav. Brain Res. 61:1994;205-214.
11. 2-mediated motor behavior in rats depleted of dopamine as neonates. Dev. Psychobiol. 27:1994;409-424.
12. 1 dopamine receptor. The search for a function Synapse. 1:1987;347-388.
13. Creese I., Burt D.R., Snyder S.H. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science. 197:1977;596-598.
14. 1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats J. Neurosci. 9:1989;125-133.
15. Descarries L., Soghomonian J.J., Garcia S., Doucet G.L., Bruno J.P. Ultrastructural analysis of the serotonin hyperinnervation in adult rat neostriatum following neonatal dopamine denervation with 6-hydroxydopamine. Brain Res. 569:1992;1-13.
16. 1 receptors in adult rat striatum after neonatal 6-hydroxydopamine denervation. Brain Res. 536:1990;287-296.
17. Duncan G.E., Criswell H.E., McCown T.J., Paul I.A., Mueller R.A., Breese G.R. Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 243:1987;1027-1033.
18. 1 dopamine receptors during postnatal development J. Neurochem. 61:1993;1255-1262.
19. Frohna P.A., Neal-Beliveau B.S., Joyce J.N. Neonatal 6-hydroxydopamine lesions lead to opposing changes in the levels of dopamine receptors and their mRNAs. Neuroscience. 68:1995;505-518.
20. Frohna P.A., Neal-Beliveau B.S., Joyce J.N. Delayed plasticity of the mesolimbic dopamine system following neonatal 6-OHDA lesions. Synapse. 25:1997;293-305.
21. 1 receptor development depends on endogenous dopamine. Dev. Brain Res. 56:1990;137-140.
22. Gerfen C.R., Baimbridge K.G., Thibault J. The neostriatal mosaic. III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems J. Neurosci. 7:1987;3935-3944.
23. Johnson B.J., Bruno J.P. D-1 and D-2 receptor mediation of sensorimotor behavior in rats depleted of dopamine during development. Behav. Brain Res. 47:1992;49-58.
24. Joyce J.N. Differential response of striatal dopamine receptor subtypes to the loss of dopamine following 6-hydroxydopamine or reserpine treatment. Exp. Neurol. 113:1991;261-276.
25. Joyce J.N., Frohna P., Neal-Beliveau B.S. Functional and molecular differentiation of the dopamine system induced by neonatal denervation. Neurosci. Biobehav. Rev. 20:1996;453-486.
26. Kostrzewa R.M. Dopamine receptor supersensitivity. Neurosci. Biobehav. Rev. 19:1995;1-17.
27. Kostrzewa R.M., Brus R., Perry K.W., Fuller R.W. Age-dependence of 6-hydroxydopamine lesion on SKF38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. Dev. Brain Res. 76:1993;87-93.
28. 1 binding density following mesotelencephalic 6-hydroxydopamine injections. An autoradiographic analysis Brain Res. 493:1989;247-257.
29. Marshall J.F., Richardson J.S., Teitelbaum P. Nigrostriatal bundle damage and the lateral hypothalamic syndrome. J. Comp. Physiol. Psychol. 87:1974;808-830.
30. Murray A.M., Waddington J.L. Further evidence for two directions of D-1:D-2 dopamine receptor interactions revealed concurrently in distinct elements of typical and atypical behavior. Studies with the new enantioselective D-2 agonist LY 163502 Psychopharmacology (Berlin). 98:1989;245-250.
31. Murray A.M., Waddington J.L. The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists. Two directions of D-1:D-2 interaction Eur. J. Pharmacol. 160:1989;377-384.
32. 1 receptor development in the rat striatum. Early localization in striosomes Brain Res. 480:1989;170-177.
33. 1 receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development. Dev. Brain Res. 60:1991;105-113.
34. 2 receptors. Synapse. 11:1992;35-46.
35. 2 dopamine receptors do not up-regulate in response to neonatal intrastriatal 6-hydroxydopamine lesions. Neurosci. Lett. 160:1993;77-80.
36. Neal-Beliveau B.S., Joyce J.N. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development. Dev. Psychobiol. 32:1998;313-326.
37. 3H-spiroperidol binding to rat forebrain sections. Plasticity of neostriatal dopamine receptors after nigrostriatal injury Brain Res. 302:1984;9-18.
38. 2 receptors in adult rat neostriatum after neonatal dopamine denervation. Quantitative data from ligand binding, in situ hybridization and iontophoresis Neuroscience. 57:1993;635-648.
39. 2 receptor subtypes in rat basal ganglia. A quantitative autoradiographic study Dev. Brain Res. 60:1991;167-177.
40. Rosengarten H., Schweitzer J.W., Friedhoff A.J. Induction of oral dyskinesia in naive rats by D-1 stimulation. Life Sci. 33:1983;2479-2482.
41. Schallert T., Petrie B.F., Whishaw I.Q. Neonatal dopamine depletion. Spared and unspared sensorimotor and attentional disorders and effects of further depletion in adulthood Psychobiology. 17:1989;386-396.
42. 1-dopamine receptors in lateral but not medial striatum following 6-hydroxydopamine-induced lesions in the neonatal rat. J. Pharmacol. Exp. Ther. 263:1992;1454-1463.
43. Snyder G.L., Zigmond M.J., Lund R.D. Sprouting of serotonergic afferents into striatum after dopamine-depleting lesions in infant rats. A retrograde transport and immunocytochemical study J. Comp. Neurol. 245:1986;274-281.
44. Stachowiak M.K., Bruno J.P., Snyder A.M., Stricker E.M., Zigmond Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats. Brain Res. 291:1984;164-167.
45. Thomas W.S., Neal-Beliveau B.S., Joyce J.N. There is a limited critical period for dopamine's effect on D1 receptor expression in the developing rat neostriatum. Dev. Brain Res. 111:1998;99-106.
46. Waddington J.L., O'Boyle K.M. The D-1 dopamine receptor and the search for its functional role. From neurochemistry to behavior Rev. Neurosci. 1:1987;157-184.